Targeting Nrf2 Pathway May Help Overcome Drug Resistance in Liver Cancer
Researchers have identified that inhibiting the Nrf2 signaling pathway can restore sensitivity to regorafenib in liver cancer cells that have developed resistance to standard treatments.
Key points
- Liver cancer cells resistant to sorafenib often show cross-resistance to regorafenib.
- Upregulation of the Nrf2 pathway is linked to this drug resistance.
- Inhibiting Nrf2 in laboratory models restored the effectiveness of regorafenib.
A recent study published in Scientific Reports explores potential strategies to address treatment resistance in hepatocellular carcinoma (HCC), the most common form of primary liver cancer. While sorafenib is a standard systemic therapy for HCC, many patients eventually develop resistance, which also appears to limit the effectiveness of subsequent treatments like regorafenib.
Researchers at Ege University investigated the role of the Nrf2 pathway in these resistant cells. Using HuH-7 and Mahlavu cell lines, the team observed that cells resistant to sorafenib showed higher levels of Nrf2 expression. When the researchers suppressed the Nrf2 pathway, they observed a significant decrease in cell viability and migration, alongside an increase in markers associated with programmed cell death.
The study demonstrated that combining Nrf2 inhibition with regorafenib significantly reduced tumor growth in 3D spheroid models. These findings suggest that targeting the Nrf2 pathway could be a viable strategy to enhance the efficacy of current second-line therapies for patients whose cancer has progressed after initial treatment.
What to know: This study was conducted exclusively in vitro using cell cultures and does not involve human or animal subjects. As this is early-stage laboratory research, these findings cannot be applied to clinical practice without further investigation. Always consult with an oncologist regarding specific cancer treatment options.
Source Nature Health Sciences — nature.com/articles/s41598-026-79897-x ↗
Read next
🏃FitnessUnderstanding and Addressing Love Handles Through Lifestyle Changes
Experts clarify that spot reduction of fat is not physiologically possible, recommending a combination of calorie management and high-intensity interval training instead.
🏃FitnessCiele Releases New Woolmark-Certified Merino Winter Running Apparel
Montreal-based brand Ciele has launched its second collection of merino wool running gear, featuring performance-focused fabrics designed for cold-weather training.
🏥Public HealthPreventive Services Task Force Resumes Meetings Under New Leadership
The U.S. Preventive Services Task Force is set to reconvene this week for the first time in over a year following a significant membership overhaul by Health Secretary Ro…
❤️Conditions & CareBlood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma
Researchers have identified a specific RNA signature in blood plasma that may help predict how well lymphoma patients respond to CAR T-cell therapy.
🧠AI AnalysisUltraprocessed Diets May Impact Brain Reward Systems in Younger Adults
A Virginia Tech study suggests that individuals aged 18 to 21 may experience changes in brain reward processing after consuming ultraprocessed foods, a response not obser…
🧠Mind & Mental HealthAddressing Body Image and the Reality of Gluteal Anatomy
A personal reflection on the social and psychological impact of body shape, specifically regarding the gluteal region, and the limitations of consumer solutions for perce…